Abstract
The original goal of the cancer marker program was to be able to measure a marker in serum that could be used to diagnose cancer when it was still small enough to be removed surgically. if this had been possible using a simple serum marker assay, many patients otherwise doomed to die of their cancer, could be cured. Unfortunately, for most cancers, if a malignant tumor cannot be removed surgically, other forms of therapy, though often effective, are usually not curable, and often have serious deleterious side effects. Even a small tumor, the size of a peanut, contains millions of living cancer cells. Chemo-, radio-, or immunotherapy may be able to eliminate 99.99% of the tumor cells. The small fraction of residual viable tumor cell are able to poliferate, develop resistance to further therapy, and eventually kill the patient. Unfortunately, for many cancers, the goal of detecting and localizing cancer, when it is still small enough to be removed surgically, remains the rare exception to the general rule.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abelev, G. I., S. D. Perova, N. I. Khramkova, Z. A. Postnikova, and I. S. Irlin (1963), Transplantation 1,174–180.
Bagshawe, K. D., H. Wilson, P. Dublon, A. Smith, M. Baldwin, and A. Kardana (1973), J. Ob. Gyn. 80,461.
Bence-Jones, H. (1867), Lancet 2, 269.
Bjorklund, B. and V. Bjorklund (1957), Arch. Allergy 10,153.
Bonfer, J. M. G. (1990), Tumor Biol. 11, 287.
Chen, D. S. and J. L. Sung (1977), Cancer 40, 779.
Go, V. (1976), Cancer 7 562–566.197.
Gold, P. and S. O. Freeman (1965), J. Exp. Med. 121, 439.
Gutman, E. B., E. E. Sproul, and A. B. Gutman (1936), Am. J. Cancer 28, 485.
Heyward, W. L., A. P. Lanier, B. J. McMahon, M. A. Fitzgerald, S.Kilkenny, and T. R. Paprocki (1985), J. Am. Med Assoc. 254, 3092.
Leong, A. S.-Y. and J. Wright (1987), Histopathology 11, 1295.
Magnani, J. L., B. Nilsson, M. Brockhaus, D. Zopf, Z. Steplewski, H. Koprowski, and V. Ginsburg (1982), J. Biol. Chem. 257, 14365.
Pontes, J. E. (1983), J. Urology 130,1037–1047.
Rosen, S. W., B. D. Weintraub, J. L.Vaitukaitis, H. H. Sussman, J. M. Hershman, and F. M. Muggia (1975), Ann. Inter. Med. 82, 71–83.
Tatarinov, Y. (1984), Vopr. Med. Khim. 10, 90–91.
Weber, K., M. Osborn, R. Moll, B. Wiklund, and B. Lüning (1984), EMBO J. 3, 2707.
Xu, K. L. (1983), in Oncodevelopmental Markers (Fishman, W., ed.), Academic, San Diego, pp. 395–408.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sell, S. (1992). Cancer Markers of the 1990s. In: Sell, S. (eds) Serological Cancer Markers. Contemporary Biomedicine, vol 11. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0401-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0401-5_1
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6745-4
Online ISBN: 978-1-4612-0401-5
eBook Packages: Springer Book Archive